Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Prepaid Assets (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Prepaid Assets for 3 consecutive years, with $10.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Prepaid Assets rose 545.53% to $10.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $10.5 million, a 545.53% increase, with the full-year FY2024 number at $10.5 million, up 545.53% from a year prior.
  • Prepaid Assets was $10.5 million for Q4 2024 at Centessa Pharmaceuticals, up from $2.0 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $22.7 million in Q3 2023 to a low of $1.6 million in Q4 2023.
  • A 3-year average of $13.5 million and a median of $18.0 million in 2024 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: plummeted 91.87% in 2023, then soared 545.53% in 2024.
  • Centessa Pharmaceuticals' Prepaid Assets stood at $19.9 million in 2022, then tumbled by 91.87% to $1.6 million in 2023, then skyrocketed by 545.53% to $10.5 million in 2024.
  • Per Business Quant, the three most recent readings for CNTA's Prepaid Assets are $10.5 million (Q4 2024), $2.0 million (Q2 2024), and $18.0 million (Q1 2024).